Claim Your Author Page
BACKGROUND The predictive value of microRNAs (miRNAs) in tumour cells and infiltrating immune cells for the efficacy of chemoradiation (CRTX) in locally advanced head and neck squamous cell carcinoma… (More)
6047Background: Mutational load and immune expression signatures have previously been established as efficacy biomarkers in immune checkpoint inhibitor (ICI) trials. It is important to know the val...
BACKGROUND Tumour mutational burden (TMB) estimated from whole exome sequencing or comprehensive gene panels has previously been established as predictive factor of response to immune checkpoint… (More)
6056Background: Immune-related gene expression signatures as candidate predictive biomarkers for cisplatin (CDDP)- and mitomycin C (MMC)-based chemoradiation (CRTX) were established in oropharyngea...